Advanced Asbestos Solutions Ltd

The TUC today (Monday) welcomed a decision by NICE to recommend the use of Alimta for some mesothelioma patients.

TUC General Secretary Brendan Barber said: 'This is a victory for all the victim support groups, parliamentarians and trade unions who have campaigned for a change of heart from NICE - but more importantly it is a victory for the patients themselves, who will now have national access to the one drug that has been shown to both extend their lives and also relieve their pain.

'We hope that all Primary Care Trusts will make Alimta available immediately to all mesothelioma patients who are likely to benefit from it.'

TUC - 09 July, 2007